• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Apela/Elabela/Toddler:心力衰竭分子机制的新视角

Apela/Elabela/Toddler: New perspectives in molecular mechanism of heart failure.

作者信息

Sunjaya Anthony P, Sunjaya Angela F, Ferdinal Frans

机构信息

Department of Biochemistry and Molecular Biology, Faculty of Medicine, Tarumanagara University, Jl. Letjen S. Parman No. 1, Jakarta, Indonesia.

出版信息

Glob Cardiol Sci Pract. 2019 Sep 20;2019(2):e201915. doi: 10.21542/gcsp.2019.15.

DOI:10.21542/gcsp.2019.15
PMID:31799290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6865182/
Abstract

Despite significant therapeutic advances, heart failure (HF) remains unacceptably high in morbidity and mortality. Additionally, its high-care and costs make HF a deadly and costly disease. First reported independently by two group of researchers, Apela/Elabela/Toddler (ELA) is the second endogenous apelin-receptor ligand discovered which is encoded from a previously classified non-coding gene, and has emerged as a key signalling-pathway in the cardiovascular system. To explore and summarise the biological effects and diagnostic potential of ELA as a new biomarker for heart failure. ELA (prepro-ELA 54 AA) is a molecule with three isoforms (ELA 11,16 and 32), recently identified as the second endogenous ligand to APJ-receptor and functions to mediate early cardiac development during zebrafish embryogenesis by inducing cardiogenesis, vasculogenesis and bone formation. In adults, it enhances cardiac contractility, promotes vasodilatory effects, mediates fluid homeostasis, reduces food intake, limits kidney dysfunction and exerts anti-atherosclerotic as well as anti-oxidative properties. These results show that ELA, an endogenous agonist of the APJ-receptor exerts cardiovascular effects comparable and potentially more potent than apelin and is found to be downregulated in experimental models and humans with heart failure.

摘要

尽管在治疗方面取得了重大进展,但心力衰竭(HF)的发病率和死亡率仍然高得令人无法接受。此外,其高昂的护理需求和成本使HF成为一种致命且代价高昂的疾病。Apela/Elabela/Toddler(ELA)由两组研究人员分别首次报道,是发现的第二种内源性apelin受体配体,由一个先前分类为非编码基因编码,已成为心血管系统中的关键信号通路。为了探索和总结ELA作为心力衰竭新生物标志物的生物学效应和诊断潜力。ELA(前体-ELA 54个氨基酸)是一种具有三种异构体(ELA 11、16和32)的分子,最近被确定为APJ受体的第二种内源性配体,在斑马鱼胚胎发育过程中通过诱导心脏发生、血管生成和骨形成来介导早期心脏发育。在成体中,它增强心脏收缩力,促进血管舒张作用,介导液体稳态,减少食物摄入,限制肾功能障碍,并具有抗动脉粥样硬化和抗氧化特性。这些结果表明,ELA作为APJ受体的内源性激动剂,发挥的心血管效应与apelin相当,甚至可能更强,并且在心力衰竭的实验模型和人类中被发现表达下调。

相似文献

1
Apela/Elabela/Toddler: New perspectives in molecular mechanism of heart failure.Apela/Elabela/Toddler:心力衰竭分子机制的新视角
Glob Cardiol Sci Pract. 2019 Sep 20;2019(2):e201915. doi: 10.21542/gcsp.2019.15.
2
The Elabela-APJ axis: a promising therapeutic target for heart failure.Elabela-APJ 轴:心力衰竭有前途的治疗靶点。
Heart Fail Rev. 2021 Sep;26(5):1249-1258. doi: 10.1007/s10741-020-09957-5.
3
ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.ELABELA-APJ 轴可预防压力超负荷性心力衰竭和血管紧张素 II 诱导的心脏损伤。
Cardiovasc Res. 2017 Jun 1;113(7):760-769. doi: 10.1093/cvr/cvx061.
4
Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling.Apela通过与APJ受体结合以激活Gi信号传导来调节液体稳态。
J Biol Chem. 2015 Jul 24;290(30):18261-8. doi: 10.1074/jbc.M115.648238. Epub 2015 May 20.
5
Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension.埃拉贝拉/Toddler是成人心血管系统中阿片肽APJ受体的内源性激动剂,外源性给予该肽可补偿其在肺动脉高压中表达的下调。
Circulation. 2017 Mar 21;135(12):1160-1173. doi: 10.1161/CIRCULATIONAHA.116.023218. Epub 2017 Jan 30.
6
Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system.阿片肽/艾拉贝拉-APJ:心血管系统中的新型治疗靶点。
Ann Transl Med. 2020 Mar;8(5):243. doi: 10.21037/atm.2020.02.07.
7
Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology.Apelin 和 Elabela/Toddler;APJ/Apelin 受体在心脏发育、生理和病理中的双重配体。
Peptides. 2019 Jan;111:62-70. doi: 10.1016/j.peptides.2018.04.011. Epub 2018 Apr 21.
8
A promising therapeutic peptide and preventive/diagnostic biomarker for age-related diseases: The Elabela/Apela/Toddler peptide.一种针对与年龄相关疾病的有前景的治疗性肽和预防/诊断生物标志物:艾拉贝拉/阿佩拉/托德乐肽。
Ageing Res Rev. 2023 Nov;91:102076. doi: 10.1016/j.arr.2023.102076. Epub 2023 Sep 29.
9
APJ as Promising Therapeutic Target of Peptide Analogues in Myocardial Infarction- and Hypertension-Induced Heart Failure.APJ作为肽类似物在心肌梗死和高血压诱导的心力衰竭中的有前景的治疗靶点。
Pharmaceutics. 2023 May 4;15(5):1408. doi: 10.3390/pharmaceutics15051408.
10
Advances in the study of ELABELA in renal physiological functions and related diseases.埃拉贝拉(ELABELA)在肾脏生理功能及相关疾病研究中的进展
Front Pharmacol. 2023 Oct 31;14:1276488. doi: 10.3389/fphar.2023.1276488. eCollection 2023.

引用本文的文献

1
Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes-A Pilot Study.慢性和急性冠状动脉综合征患者血浆中阿片肽系统成分水平的初步研究
J Clin Med. 2021 Sep 26;10(19):4420. doi: 10.3390/jcm10194420.
2
Apela inhibits systemic and renal inflammatory reactions in mice with type I cardiorenal syndrome.阿哌沙班抑制 I 型心肾综合征小鼠的全身和肾脏炎症反应。
FASEB J. 2021 Oct;35(10):e21907. doi: 10.1096/fj.202101030R.
3
The beneficial role of vitamin B12 in injury induced by ischemia/reperfusion: Beyond scavenging superoxide?

本文引用的文献

1
Redefining biomarkers in heart failure.重新定义心力衰竭的生物标志物。
Heart Fail Rev. 2018 Mar;23(2):237-253. doi: 10.1007/s10741-018-9683-2.
2
Biological functions of Elabela, a novel endogenous ligand of APJ receptor.Elabela 的生物学功能,APJ 受体的一种新型内源性配体。
J Cell Physiol. 2018 Sep;233(9):6472-6482. doi: 10.1002/jcp.26492. Epub 2018 Mar 25.
3
Global Public Health Burden of Heart Failure.心力衰竭的全球公共卫生负担。
维生素B12在缺血/再灌注诱导损伤中的有益作用:超越清除超氧化物?
J Exp Nephrol. 2021;2(1):3-6. doi: 10.46439/nephrology.2.007.
4
Elabela: A Novel Biomarker for Right Ventricular Pressure Overload in Children With Pulmonary Stenosis or Pulmonary Atresia With Intact Ventricular Septum.艾拉贝拉:一种用于肺动脉狭窄或室间隔完整的肺动脉闭锁患儿右心室压力过载的新型生物标志物。
Front Cardiovasc Med. 2020 Nov 12;7:581848. doi: 10.3389/fcvm.2020.581848. eCollection 2020.
5
Apela improves cardiac and renal function in mice with acute myocardial infarction.阿哌沙班可改善急性心肌梗死小鼠的心肾功能。
J Cell Mol Med. 2020 Sep;24(18):10382-10390. doi: 10.1111/jcmm.15651. Epub 2020 Jul 20.
Card Fail Rev. 2017 Apr;3(1):7-11. doi: 10.15420/cfr.2016:25:2.
4
ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.ELABELA-APJ 轴可预防压力超负荷性心力衰竭和血管紧张素 II 诱导的心脏损伤。
Cardiovasc Res. 2017 Jun 1;113(7):760-769. doi: 10.1093/cvr/cvx061.
5
Elabela, a new endogenous ligand of APJ, functions in embryos and adults organisms.埃拉贝拉(Elabela)是一种新的APJ内源性配体,在胚胎和成年生物体中发挥作用。
Acta Biochim Biophys Sin (Shanghai). 2017 Apr 1;49(4):378-381. doi: 10.1093/abbs/gmx014.
6
Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension.埃拉贝拉/Toddler是成人心血管系统中阿片肽APJ受体的内源性激动剂,外源性给予该肽可补偿其在肺动脉高压中表达的下调。
Circulation. 2017 Mar 21;135(12):1160-1173. doi: 10.1161/CIRCULATIONAHA.116.023218. Epub 2017 Jan 30.
7
ELABELA Is an Endogenous Growth Factor that Sustains hESC Self-Renewal via the PI3K/AKT Pathway.ELABELA 是一种内源性生长因子,通过 PI3K/AKT 通路维持 hESC 的自我更新。
Cell Stem Cell. 2015 Oct 1;17(4):435-47. doi: 10.1016/j.stem.2015.08.010. Epub 2015 Sep 17.
8
Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system.Apelin、Elabela/Toddler及偏向性激动剂作为心血管系统中的新型治疗药物。
Trends Pharmacol Sci. 2015 Sep;36(9):560-7. doi: 10.1016/j.tips.2015.06.002. Epub 2015 Jul 1.
9
Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling.Apela通过与APJ受体结合以激活Gi信号传导来调节液体稳态。
J Biol Chem. 2015 Jul 24;290(30):18261-8. doi: 10.1074/jbc.M115.648238. Epub 2015 May 20.
10
Elabela-apelin receptor signaling pathway is functional in mammalian systems.埃拉贝拉唑-阿片肽受体信号通路在哺乳动物系统中发挥作用。
Sci Rep. 2015 Feb 2;5:8170. doi: 10.1038/srep08170.